News
After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
The researchers argue that CoT monitoring can help researchers detect when models begin to exploit flaws in their training, ...
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
The new agent, called Asimov, was developed by Reflection, a small but ambitious startup cofounded by top AI researchers from ...
Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...
Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...
The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results